Gerresheimer reports double digit growth in revenue and earnings for the third quarter

12.10.2022 | from Gerresheimer AG


Gerresheimer AG

12.10.2022, Duesseldorf - Organic revenue growth of 17.4% in the third quarter supported by continued strong demand for High Value Solutions. Organic adjusted EBITDA up 13.3%. Gerresheimer firmly on track to deliver on FY 2022 guidance.

Gerresheimer AG, a leading provider of healthcare & beauty solutions and drug delivery systems for pharma, biotech and cosmetics, confirms guidance for its financial year 2022 after another quarter of strong and profitable growth. Revenue rose organically by 17.4% in the third quarter, reflecting strong customer demand, leading market positions and the ongoing success of its High Value Solutions. Adjusted EBITDA grew organically by 13.3%. "Gerresheimer continues on its profitable growth path across all our divisions, business segments and regions reflecting our strong market positions. While steering successfully through a challenging environment, we are consistently pursuing our growth strategy and are boosting our transformation process to become a solution provider and system integrator”, said Dietmar Siemssen, CEO of Gerresheimer AG. “We are on track to deliver on our financial year 2022 guidance, and we are clearly committed to our mid-term targets”, he affirmed.

In the third quarter of its financial year 2022, Gerresheimer generated revenues of EUR 473m, representing organic growth of 17.4%. Both the Plastics & Devices and Primary Packaging Glass divisions contributed profitable double-digit revenue growth as the investments in key growth drivers, such as High Value Solutions, capacity and regional expansion as well as contract manufacturing are paying off as envisaged. Due to strong growth in High Value Solutions along with rigorous price adjustments, the adjusted EBITDA grew from EUR 75m by EUR 16m to EUR 91m. Currency adjusted this represents an organic growth of 13.3%. Adjusted earnings per share (EPS) rose from EUR 0.97 to EUR 1.15, showing an organic growth of 10.1%. Gerresheimer reaffirms its guidance for the financial year 2022 for organic revenue growth of at least 10% and high single-digit organic growth in adjusted EBITDA and adjusted EPS.

Gerresheimer has been implementing a broad range of measures to manage inflationary impacts and to ensure continuity of the supply of its system relevant solutions and services. It has long-term energy supply agreements in place which offer a very competitive cost position. Gerresheimer also continues to improve its energy mix through the consistent implementation of its sustainability strategy.

Plastics & Devices Division revenues grew organically by 11.3% supported by pass-through effects, together with strong demand for plastic packaging solutions and injectors as well as the engineering and tooling business. Adjusted EBITDA increased organically by 9.3%.

The Primary Packaging Glass Division further accelerated its organic growth with a significant increase of 24.5%. This excellent performance was driven by the continued strong demand for High Value Solutions such as Gx RTF Vials and Gx Elite Glass as well as sustainable price increases. Adjusted EBITDA rose organically by 18.9%.

The Advanced Technologies Division pushes forward with projects and investments in its future growth. This included ongoing projects for the development of a new pump for a US biotech customer as well as a micro pump for chronic heart failure treatment with SQ Innovation.

Gerresheimer continues to execute consistently on its formula G strategy process with highly attractive growth projects, including global capacity expansion and new partnerships. In recent months, Gerresheimer has announced for example, a strategic partnership with Zollner Elektronik AG (Zandt/Germany) to develop electronically controlled medtech systems, a government backed investment in additional vial-production capacity in the United States and an initiative to implement a new industry standard for high-end Ready-To-Fill (RTF) vials. At the same time, the order book in contract manufacturing is growing significantly.

Guidance for FY 2022 (For group level, FXN):

- Organic revenue growth: at least 10%

- Organic adjusted EBITDA growth: high single-digit

- Adjusted EPS growth: high single-digit

Mid-term Guidance (For group level, FXN)

- Organic revenue growth: high single-digit

- Organic adjusted EBITDA margin: of 23-25%

- Adjusted EPS growth: at least 10% p.a

About Gerresheimer
Gerresheimer is the global partner for pharmaceutics, biotech, healthcare, and cosmetics with a very broad product range for pharmaceutical and cosmetic packaging solutions and drug delivery systems. The company is an innovative solution provider from concept to delivery of the end product. Gerresheimer achieves its ambitious goals through a high level of innovative strength, industrial competence and concentration on quality and customer focus. In developing innovative and sustainable solutions, Gerresheimer relies on a comprehensive international network with numerous innovation and production centers in Europe, America and Asia. Gerresheimer produces close to its customers worldwide with around 11,000 employees and generated annual revenues in 2021 of around EUR 1.5b. With its products and solutions, Gerresheimer plays an essential role in people's health and well- being.


Contact:
Ueli Utzinger
Group Senior Director Marketing & Communication
T +41 79 400 86 40
ueli.utzinger@gerresheimer.com

Contact Investor Relations
Carolin Nadilo
Corporate Senior Director Investor Relations
T +49 211 6181-220
carolin.nadilo@gerresheimer.com

--- END press release Gerresheimer reports double digit growth in revenue and earnings for the third quarter ---

Source:
HELP.ch


More information and links:
  Gerresheimer AG (company entry)

  Gerresheimer erzielt zweistelliges Umsatz- und Ergebniswachstum im 3. Quartal (news article in german on swiss-press.com)



Swissnewsnow.com

On Swissnewsnow.com are published media releases, information from Swiss companies and Swiss authorities.

HELP Media AG on social networks
Facebook Twitter Instagram LinkedIn Pinterest Flickr

Subscription

Publish your media releases as a subscription and benefit from two free media releases.

Subscription 10 media releases (+2 free)
Subscription now »

Publish media release

To publish your own press release on Swissnewsnow.com, click on the following link:

Publish media release now »

Contact

Email:
info@help.ch

Address:
HELP Media AG
Thurgauerstrasse 40, 8050 Zurich


Copyright © 1996-2022 HELP Media AG, CH-8050 Zurich. All statements without guarantee. Terms and Conditions, Terms of Use & Privacy Policy